225 related articles for article (PubMed ID: 21481991)
1. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
Xia Y; Jin Y; Kaur N; Choi Y; Lee K
Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1 inhibitory benzofurans and chalcone-derived diels-alder adducts from Morus species.
Dat NT; Jin X; Lee K; Hong YS; Kim YH; Lee JJ
J Nat Prod; 2009 Jan; 72(1):39-43. PubMed ID: 19072214
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors.
Boovanahalli SK; Jin X; Jin Y; Kim JH; Dat NT; Hong YS; Lee JH; Jung SH; Lee K; Lee JJ
Bioorg Med Chem Lett; 2007 Nov; 17(22):6305-10. PubMed ID: 17884495
[TBL] [Abstract][Full Text] [Related]
4. (Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.
Lee K; Lee JH; Boovanahalli SK; Jin Y; Lee M; Jin X; Kim JH; Hong YS; Lee JJ
J Med Chem; 2007 Apr; 50(7):1675-84. PubMed ID: 17328532
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antiproliferative activities and in vitro biological evaluation of novel benzofuransulfonamide derivatives.
Yang L; Lei H; Mi CG; Liu H; Zhou T; Zhao YL; Lai XY; Li ZC; Song H; Huang WC
Bioorg Med Chem Lett; 2011 Sep; 21(18):5389-92. PubMed ID: 21795045
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway.
Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD
Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092
[TBL] [Abstract][Full Text] [Related]
7. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
8. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors.
Kim HS; Hong M; Lee SC; Lee HY; Suh YG; Oh DC; Seo JH; Choi H; Kim JY; Kim KW; Kim JH; Kim J; Kim YM; Park SJ; Park HJ; Lee J
Eur J Med Chem; 2015 Nov; 104():157-64. PubMed ID: 26457742
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of novel shikonin analogues.
Wang W; Dai M; Zhu C; Zhang J; Lin L; Ding J; Duan W
Bioorg Med Chem Lett; 2009 Feb; 19(3):735-7. PubMed ID: 19111464
[TBL] [Abstract][Full Text] [Related]
11. Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.
Manjulatha K; Srinivas S; Mulakayala N; Rambabu D; Prabhakar M; Arunasree KM; Alvala M; Basaveswara Rao MV; Pal M
Bioorg Med Chem Lett; 2012 Oct; 22(19):6160-5. PubMed ID: 22929231
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
13. Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery.
Yewalkar N; Deore V; Padgaonkar A; Manohar S; Sahu B; Kumar P; Jalota-Badhwar A; Joshi KS; Sharma S; Kumar S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6426-9. PubMed ID: 20932758
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of (E)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1α inhibitors.
Naik R; Won M; Kim BK; Xia Y; Choi HK; Jin G; Jung Y; Kim HM; Lee K
J Med Chem; 2012 Dec; 55(23):10564-71. PubMed ID: 23153200
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
[TBL] [Abstract][Full Text] [Related]
16. Novel flavaglines displaying improved cytotoxicity.
Thuaud F; Ribeiro N; Gaiddon C; Cresteil T; Désaubry L
J Med Chem; 2011 Jan; 54(1):411-5. PubMed ID: 21142180
[TBL] [Abstract][Full Text] [Related]
17. A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway.
Won MS; Im N; Park S; Boovanahalli SK; Jin Y; Jin X; Chung KS; Kang M; Lee K; Park SK; Kim HM; Kwon BM; Lee JJ; Lee K
Biochem Biophys Res Commun; 2009 Jul; 385(1):16-21. PubMed ID: 19433063
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole.
Chen W; Yang XD; Li Y; Yang LJ; Wang XQ; Zhang GL; Zhang HB
Org Biomol Chem; 2011 Jun; 9(11):4250-5. PubMed ID: 21505704
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
20. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]